Therapeutic effects of ecabet sodium, an antiulcer drug, on dextran sodium sulfate-induced ulcerative colitis in rats

Digestive Diseases and Sciences

Volumn 50, Issue 5, 2005, Pages 922-927

  Noto, Tsunehisa ^a,b   Yamada, Hiroshi ^a   Inui, Takashi ^a   Okuyama, Kayoko ^a   Watanable, Ayako ^a   Kimura, Isami ^a   Nagasaki, Masaaki ^a  

^a Discov and Pharmacol Res Labs   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

5 lipoxygenase; Leukotriene B4; Restitution; TGF

Indexed keywords

12 SULFODEHYDROABIETIC ACID; ANTIULCER AGENT; ARACHIDONATE 5 LIPOXYGENASE; DEXTRAN SULFATE; DRINKING WATER; LEUKOTRIENE B4; MESALAZINE; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EPITHELIUM CELL; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; ULCERATIVE COLITIS;

ADMINISTRATION, RECTAL; ANIMALS; ANTI-ULCER AGENTS; CELL CULTURE TECHNIQUES; COLITIS, ULCERATIVE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DITERPENES, ABIETANE; ENEMA; ENTEROCYTES; HUMANS; MALE; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 18844405759     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2665-y     Document Type: Article

References (22)

1. Ito Y, Sugawara Y, Takaiti O, Nakamura S: Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7- (1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). II. Distribution in the rat stomach. J Pharmacobiodyn 14(9):547-554, 1991
2. Ito Y, Fukushima T, Sugawara Y, Takaiti O, Nakamura S: Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9,10,10a-octahydro-1,4a- dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). I. Disposition, metabolism and protein binding in rats and dogs. J Pharmacobiodyn 14(9):533-546, 1991
3. Furukawa O, Kume E, Sugamoto S, Kawauchi S, Takeuchi K: Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro. Digestion 62(2-3):116-125, 2000
4. Ichikawa T, Ishihara K, Hayashida H, Hiruma H, Saigenji K, Hotta K: Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa. Dig Dis Sci 45(3):606-613, 2000
5. Onoda Y, Takido M, Magaribuchi T, Tamaki H: Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new antiulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats. Jpn J Pharmacol 52(4):631-638, 1990
6. Kono T, Nomura M, Kasai S, Kohgo Y: Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study. Am J Gastroenterol 96(3):793-797, 2001
7. Kimura I, Kawasaki M, Nagahama S, Matsuda A, Kataoka M, Kokuba Y: Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats. Arzneimittelforschung 48(11):1091-1096, 1998
8. Ciacci C, Lind SE, Podolsky DK: Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 105(1):93-101, 1993
9. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97:77-89, 1968
10. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
11. Kinoshita M, Kume E, Tamaki H: Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium. J Pharmacol Exp Ther 275(1):494-501, 1995
12. Kinoshita M, Iwasaki H, Yasoshima A, Tamaki H: Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats. Biol Pharm Bull 16(12):1220-1225, 1993
13. Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJ, Moncada S: Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 342(8867):338-340, 1993
14. Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, Caprilli R: Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci 44(7):1458-1475, 1999
15. Kawakami K, Yasuda M, Ishii K, Kokusenya Y, Sato T: A kinetic study of protein binding to ecabet sodium using quartz-crystal microbalance. Chem Pharm Bull (Tokyo) 47(7):919-922, 1999
16. Dignass AU: Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 7(1):68-77, 2001
17. Dignass AU, Podolsky DK: Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 105(5):1323-1332, 1993
18. Laursen LS, Naesdal J, Bukhave K, Lauritsen K, Rask-Madsen J: Selective 5-lipoxygenase inhibition in ulcerative colitis. Lancet 335(8691):683-685, 1990
19. Sharon P, Stenson WF: Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86(3):453-160, 1984
20. Kimura I, Nagahama S, Kawasaki M, Kataoka M, Sato M: Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (3). Nippon Yakurigaku Zasshi 108(5):259-266, 1996
21. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286(5770):264-265, 1980
22. Eliakim R, Karmeli F, Chorev M, Okon E, Rachmilewitz D: Effect of drugs on colonic eicosanoid accumulation in active ulcerative colitis. Scand J Gastroenterol 27(11):968-972, 1992